Skip to main content
SpringerLink
Log in

Prognostic value of microscopic peritoneal dissemination

Comparison between colon and gastric cancer

  • Original Contributions
  • Published:
Diseases of the Colon & Rectum

Abstract

PURPOSE: We evaluated the incidence and prognostic relevance of microscopic intraperitoneal tumor cell dissemination of colon cancer in comparison with dissemination of gastric cancer as a rational for additive intraperitoneal therapy. METHODS: Peritoneal washouts of 90 patients with colon and 111 patients with gastric cancer were investigated prospectively. Sixty patients with benign diseases and 8 patients with histologically proven gross visible peritoneal carcinomatosis served as controls. Intraoperatively, 100 ml of warm NaCl 0.9 percent were instilled and 20 ml were reaspirated. In all patients hematoxylin and eosin staining (conventional cytology) was performed. Additionally, in 36 patients with colon cancer and 47 patients with gastric cancer, immunostaining with the HEA-125 antibody (immunocytology) was prepared. The results of cytology were assessed for an association with TNM category and cancer grade, based on all patients, and with patient survival, among the R0 resected patients. RESULTS: In conventional cytology 35.5 percent (32/90) of patients with colon cancer and 42.3 percent (47/111) of patients with gastric cancer had a positive cytology. In immunocytology 47.2 percent (17/36) of patients with colon cancer and 46.8 percent (22/47) of patients with gastric cancer were positive. In colon cancer, positive conventional cytology was associated with pT and M category (P=0.044 andP=0.0002), whereas immunocytology was only associated with M category (P=0.007). No association was found between nodal status and immunocytology in colon cancer and with the grading. There was a statistically significant correlation between pT M category and conventional and immunocytology in gastric cancer (P<0.0015/P=0.007 andP<0.001/P=0.009, respectively). Positive immunocytology was additionally associated with pN category (P=0.05). In a univariate analysis of R0 resected patients (no residual tumor), positive immunocytology was significantly related to an unfavorable prognosis in patients with gastric cancer only (n=30). Mean survival time was significantly increased in patients with gastric cancer with negative cytology compared with positive cytology (1,205 (standard error of the mean, 91)vs. 771 (standard error of the mean, 147) days;P=0.007) but not in patients with colon cancer (1,215 (standard error of the mean, 95)vs. 1,346 (standard error of the mean, 106) days;P=0.55). CONCLUSIONS: Because microscopic peritoneal dissemination influences survival time after R0 resections only in patients with gastric but not with colon cancer, our results may provide a basis for a decision on additive, prophylactic (intraperitoneal) therapy in gastric but not colon cancer.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Brodsky JT, Cohen AM. Peritoneal seeding following potentially curative resection of colonic carcinoma: implications for adjuvant therapy. Dis Colon Rectum 1991;43:723–7.

    Google Scholar 

  2. Maeta M, Sugesawa A, Ikeguchi M,et al. Does the extent of lymph node dissection affect the postoperative survival of patients with gastric cancer and disseminating peritoneal metastasis. Surg Today 1994;24:40–2.

    Google Scholar 

  3. Takahashi T, Hagiwara A, Shimotsuma M, Sawai K, Yamaguchi T. Prophylaxis and treatment of peritoneal carcinomatosis: Intraperitoneal chemotherapy with mitomycin C bound activated carbon particles. World J Surg 1995;19:565–9

    Google Scholar 

  4. Lindemann F, Schlimok G, Dirschedl P, Witte J, Riethmüller G. Prognostic significance of micrometastatic tumour cells in bone marrow of colorectal cancer patients. Lancet 1992;340:685–9.

    Google Scholar 

  5. Sugarbaker PH, Gianola FJ, Peyer JL, Wesley R, Barofsky I, Myers CE. Prospective randomized trial of intravenous vs intraperitoneal 5-FU in patients with a primary colon or rectal cancer. Semin Oncol 1985;12:101–11.

    Google Scholar 

  6. Cordell JL, Falini B, Erber WN. Immunoenzymatic labeling of monoclonal antibodies using immune complexes of alkaline phosphatases (APAAP complexes). J Histochem Cytochem 1984;32:219–29.

    Google Scholar 

  7. Spiessl B, Beahrs OH, Hermanek P,et al. UICC TNM atlas. 3rd ed. Berlin: Springer-Verlag, 1993.

    Google Scholar 

  8. Weiss SM, Skibber JM, Mohiuddin M., Rosato FE. Rapid intra-abdominal spread of pancreatic cancer. Arch Surg 1985;120:415–6.

    Google Scholar 

  9. Roscher R, Frank R, Wagner R, Safi F, Beger HG. Chirurgische Behandlungsergebnisse beim Dickdarmileus. Chirurg 1991;62:201–5.

    Google Scholar 

  10. Maehara Y, Kakeji Y, Takahashi I,et al. Noncurative resection for advanced gastric cancer. J Surg Oncol 1992;51:221–5.

    Google Scholar 

  11. Baba H, Okuyama T, Hiroyuki O,et al. Prognostic factors for noncurative gastric cancer: univariate and multivariate analysis. J Surg Oncol 1992;51:104–8.

    Google Scholar 

  12. Sautner T, Hofbauer F, Depisch D, Schiessel R, Jakesz R. Adjuvant intraperitoneal cisplatin chemotherapy does not improve long term survival after surgery for advanced gastric cancer. J Clin Oncol 1994;12:970–4.

    Google Scholar 

  13. Juhl H, Stritzel M, Wroblewski A,et al. Immunocytological detection of micrometastatic cells: comparative evaluation of findings in the peritoneal cavity and the bone marrow of gastric, colon and pancreatic cancer patients. Int J Cancer 1994;57:330–5.

    Google Scholar 

  14. Broll R, Lembcke K, Stock C,et al. Tumorzelldissemination in das Knochenmark und die Peritonealhöhle. Langenbecks Arch Chir 1996;381:51–8

    Google Scholar 

  15. Juhl, H, Kalthoff H, Krüger U, Henne-Bruns D, Kremer B. Immunzytologischer Nachweis mikrometastatischer Zellen bei Patienten mit gastrointestinalen Tumoren. Zentralbl Chir 1995;120:116–22.

    Google Scholar 

  16. Los G, McVie JG. Experimental and clinical status of intraperitoneal chemotherapy. Eur J Cancer 1990;26:755–62.

    Google Scholar 

  17. Crooks P, Leichman CG, Leichman L,et al. Systemic chemotherapy for gastric carcinoma followed by post-operative intraperitoneal therapy. Cancer 1997;79:1767–75.

    Google Scholar 

  18. Sugarbaker PH, Jablonski KA. Prognostic features of 51 colon and 130 appendiceal cancer patients with peritoneal carcinomatosis treated by cytoreductive surgery and intraperitoneal chemotherapy. Ann Surg 1995;221:124–32.

    Google Scholar 

  19. Kelsen DP, Saltz I, Cohen AM,et al. A phase I trial of immediate postoperative intraperitoneal floxuridine and leucovorin plus systemic 5-fluorouracil and levamisole after resection of high risk colon cancer. Cancer 1994;74:2224–33.

    Google Scholar 

  20. Ambrose NS, MacDonald F, Young J, Thompson H, Keighly MR. Monoclonal antibody and cytological detection of free malignant cells in the peritoneal cavity during resection of colon cancer—can monoclonal antibodies do better? Eur J Surg Oncol 1989;15:99–102.

    Google Scholar 

  21. Leather AJ, Kocjan G, Savage F,et al. Detection of free malignant cells in the peritoneal cavity before and after resection of colorectal cancer. Dis Colon Rectum 1994;37:814–9.

    Google Scholar 

  22. Kuhlmann L, Berghauser KH, Schaffer H. Distinction of mesothelioma from carcinoma in pleural effusions. An immunocytochemical study on routinely processed cytoblock preparations. Pathol Res Pract 1991;187:467–71.

    Google Scholar 

  23. Simon B, Podolsky DK, Moldenhauer G, Isselbacher KJ, GattoniCelli S, Brand SJ. Epithelial glycoprotein is a member of a family of epithelial cell surface antigens homologous to nidogen, a matrix adhesion protein. Proc Natl Acad Sci U S A 1990;87:2755–9.

    Google Scholar 

  24. Tupitsyn NN, Kadagidze ZG, Blokhina NG,et al. The expression of leukocytic and related antigens on the cells of human breast cancer cells [in Russian]. Eksp Onkol 1990;12:54–8.

    Google Scholar 

  25. Gottschalk J, Jautzke G, Zimmer C, Cervos-Navarro J. HEA-125 and BER EP4: two monoclonal anti-epithelial, non-cytokeratin antibodies distinguishing metastatic carcinomas from glial tumors. Clin Neuropathol 1993;12:68–72.

    Google Scholar 

  26. Iitsuka Y, Shiota S, Matsui T, Murata Y, Kimura A, Koga S. Relationship between the cytologic characteristics of intraperitoneal free cancer cells and the prognosis in patients with gastric cancer. Acta Cytol 1990;34:437–42.

    Google Scholar 

  27. Boku T, Nakane Y, Minoura T,et al. Prognostic significance of serosal invasion and free intraperitoneal cancer cells in gastric cancer. Br J Surg 1990;77:436–9.

    Google Scholar 

  28. Akama F, Kajiwara K, Ishikawa H, Minami H, Nakamura Y. Cytological examination of abdominal washings in gastric cancer surgery. In: Siewert JR, Roder JD, eds. Progress in gastric cancer research, 1997. Bologna: Monduzzi Editore S.p.A, 1997.

    Google Scholar 

  29. Bonenkamp JJ, Songun I, Hermans J, van de Velde CH. Prognostic value of positive cytology findings from abdominal washings in patients with gastric cancer. Br J Surg 1996;83:672–4.

    Google Scholar 

  30. Lawrence RJ, Loizidou M, Cooper AJ, Alexander P, Taylor I. Importance of the omentum in the development of intra-abdominal metastases. Br J Surg 1991;78:117–9.

    Google Scholar 

  31. Lorenz R, Krestin GP, Neufang KF. Diagnostik und Differentialdiagnostik einer Peritonealkarzinose. Konventionelle Techniken, Sonographie, Computertomographie, Kernspintomographie. Radiologe 1990;30:477–80.

    Google Scholar 

  32. Ikeguchi M, Oka A, Tsujitani S, Maeta M, Kaibara N. Relationship between area of serosal invasion and intraperitoneal free cancer cells in patients with gastric cancer. Anticancer Res 1994;14:2131–4.

    Google Scholar 

  33. Abe S, Yoshimura H, Tabara H,et al. Curative resection of gastric cancer: limitation of peritoneal lavage cytology in predicting the outcome. J Surg Oncol 1995;59:226–229.

    Google Scholar 

  34. Pantel K, Schlimok G, Braun ST,et al. Differential expression of proliferation associated molecules in individual micrometastatic carcinoma cells. J Natl Cancer Inst 1993;85:1419–24.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. From the Department of Surgery, University of Regensburg, Regensburg

    Peter Vogel M.D., Sabine Kümmel M.D., Hubert Zirngibl M.D. & K. -W. Jauch M.D.

  2. Institute of Pathology, University of Regensburg, Regensburg

    Josef Rüschoff M.D. & Ferdinand Hofstädter M.D.

  3. Department of Surgery, University of Erlangen-Nürnberg, Erlangen, Germany

    Werner Hohenberger M.D.

Authors
  1. Peter Vogel M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Josef Rüschoff M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Sabine Kümmel M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Hubert Zirngibl M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Ferdinand Hofstädter M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Werner Hohenberger M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. K. -W. Jauch M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

About this article

Cite this article

Vogel, P., Rüschoff, J., Kümmel, S. et al. Prognostic value of microscopic peritoneal dissemination. Dis Colon Rectum 43, 92–100 (2000). https://doi.org/10.1007/BF02237250

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02237250

Key words

Search

Navigation